Key Points: Rejuran nodules form when the treatment's high-viscosity PN component is injected unevenly into the wrong skin layer, making precise injection technique the most important factor in preventing this side effect. Understanding why the same property that gives Rejuran its regenerative power can also lead to nodule formation helps you ask the right questions before your treatment.
Why Does Rejuran's PN Component Sometimes Cause Nodules?
Rejuran's regenerative effect comes from long-chain polynucleotides (PN) derived from salmon DNA. These molecules are significantly larger and more viscous than those found in standard skin booster injections, which is precisely what allows them to remain in the tissue longer and stimulate sustained dermal remodeling.
Because of this high viscosity, PN does not diffuse as freely through tissue as lighter hydrating injectables do. If the material is deposited in the wrong layer or concentrated in one spot rather than distributed evenly, it can accumulate into a firm, painless lump known as a nodule. This is not a sign that regeneration is working harder — it simply means the product has not spread uniformly through the dermis.
It is important to understand that prolonged embossing on the skin surface does not equal better results. Dermal density improvement depends on the product spreading evenly within the tissue. The high viscosity that makes Rejuran effective is therefore a double-edged quality: beneficial when distributed correctly, and a potential risk factor when it is not.
This physical reality means the outcome of your treatment is closely tied to the injector's understanding of skin layer anatomy and their ability to adapt technique to your individual skin thickness.
What Injection Techniques Help Prevent Rejuran Nodule Formation?
Preventing nodules requires distributing the product in small, evenly spaced deposits rather than concentrating larger volumes in a single location. This approach reduces the chance of the viscous PN pooling in one area and forming a palpable lump beneath the skin.
In areas where the skin is naturally thin — such as around the eyes or along the neck — injection pressure must be controlled with particular care. Even a slight excess of pressure or volume in these zones can push the product into the wrong plane, increasing nodule risk. Adjusting the needle entry angle to match the actual skin thickness of each area is a key part of controlling this.
Spacing injections closely and distributing the total dose across multiple precise points also helps prevent metabolic stagnation within the tissue, which is another mechanism through which clumping can develop. The goal is for the product to integrate smoothly into the surrounding dermis rather than sitting as a discrete deposit.
At Onu Clinic, the approach is to deliver the exact amount needed at each location — no more — so that recovery feels comfortable and natural, and the results reflect even tissue improvement rather than surface irregularity.
How to manage Rejuran side effects including inflammation and embossing
How Does a Thorough Pre-Treatment Assessment Reduce Nodule Risk?
Before any injection, accurately assessing each patient's skin barrier condition and dermal thickness is the foundation of safe Rejuran treatment. This assessment directly informs decisions about injection depth, volume per point, and the appropriate interval between sessions — all of which affect whether nodules are likely to form.
At Onu Clinic, the pre-treatment consultation is used to carefully evaluate these factors so that treatment intervals can be calibrated to the individual rather than applied as a standard protocol. Recommending more frequent or higher-volume sessions than a patient's skin can realistically absorb is not considered appropriate care, regardless of commercial pressure.
The principle guiding this approach is that working within proven regenerative mechanisms — with accurate judgment and without overtreatment — produces the most reliable outcomes. Treating only what is genuinely needed at the right time and in the right amount is how adverse effects can be meaningfully minimized.
Results will always vary depending on individual skin condition, and no outcome can be guaranteed. However, a careful, individualized assessment before treatment significantly improves the likelihood that the regenerative process unfolds safely and effectively.
What Should You Look for When Choosing a Rejuran Provider?
Nodule formation following Rejuran is largely a controllable risk when the injector understands both the physical properties of the product and the anatomical variation across different facial zones. Choosing a provider who takes these factors seriously is the most practical step you can take to protect yourself.
Look for a clinic where the consultation goes beyond recommending a standard number of sessions. A practitioner who evaluates your skin barrier condition, discusses your specific concerns, and explains why a particular injection plan is appropriate for your skin — rather than applying a one-size-fits-all protocol — is more likely to deliver safe, consistent results.
It is also reasonable to ask how the clinic approaches areas of thinner skin, how they distribute product to reduce the chance of clumping, and what their process is if a nodule does develop. Transparency about technique and risk management is a meaningful indicator of clinical care standards.
Ultimately, the best outcomes come from matching treatment to what your skin genuinely needs, rather than maximizing the number of procedures. Individual differences in skin thickness, barrier health, and tissue response all influence how Rejuran behaves — and a thorough pre-assessment is what allows those differences to be properly accounted for.
Frequently Asked Questions
Are Rejuran nodules dangerous?
Rejuran nodules are typically firm, painless lumps that form when the product collects unevenly in the tissue. They are generally not dangerous, but they do indicate that the product was not distributed optimally. In many cases they resolve over time, though the timeline varies by individual. If you notice a persistent hard lump after treatment, it is worth returning to your provider for evaluation.
Why does Rejuran cause nodules more often than other skin boosters?
Rejuran contains high-molecular-weight polynucleotides (PN) that are significantly more viscous than the lighter ingredients in standard hydrating skin boosters. This viscosity is what allows it to stay in the tissue longer and support dermal regeneration — but it also means the product does not diffuse freely. If injected into the wrong layer or concentrated in one spot, it is more likely to form a clump than a thinner product would be.
Which areas of the face have the highest nodule risk with Rejuran?
Areas where the skin is naturally thinner — such as around the eyes and along the neck — carry a higher risk of nodule formation. These zones require especially careful pressure control and reduced volume per injection point. Injection technique must be adapted to the actual skin thickness of each area rather than applied uniformly across the face.
Does getting Rejuran more frequently lead to better skin results?
More frequent treatment does not necessarily mean better results. The interval between sessions should reflect each patient's skin barrier condition and how the tissue has responded to previous treatment. Injecting before the skin has adequately processed the prior session can increase the risk of product accumulation and related side effects, including nodule formation. Individual assessment is the appropriate basis for scheduling decisions.
How can I tell if my Rejuran provider is using safe injection technique?
A provider using safe technique will assess your skin thickness and barrier condition before treatment, distribute the product across multiple small injection points rather than depositing larger volumes in fewer locations, and adjust needle angle and pressure according to the area being treated. During your consultation, it is reasonable to ask how they approach thinner skin zones and how they minimize the risk of nodule formation.